AMD linked to increased incidence of death from stroke, cardiovascular events

Article

Age-related macular degeneration (AMD) may be a useful indicator for predicting death from stroke or cardiovascular disease, according to a study published online ahead of print by the British Journal of Ophthalmology.

Age-related macular degeneration (AMD) may be a useful indicator for predicting death from stroke or cardiovascular disease, according to a study published online ahead of print by the British Journal of Ophthalmology.

Jennifer S. Tan at the University of Sydney, Australia and team assessed 3654 subjects (age ≥49 years), with follow-up at five (n=2335) and 10 (n=1952) years. Assessment included physical risk factors and medical history; causes of death were confirmed by the Australian National Death Index.

Early presentation of AMD was, after adjusting for traditional cardiovascular risk factors, linked to a twofold increase in cardiovascular mortality over a 10-year period in subjects aged <75 years at baseline. Late presentation of AMD was, after adjusting for age and gender, associated with a five times increased incidence of cardiovascular mortality and a 10 times increased incidence of stroke mortality, again in subjects aged <75 years at baseline.

The researchers concluded that this association of AMD with mortality from stroke and cardiovascular events may have implications for intravitreal anti-VEGF therapies, which are also linked with an increased risk of stroke.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
© 2025 MJH Life Sciences

All rights reserved.